Australia, Oct. 22 -- Aborns Pharmaceuticals Pty. Ltd., owns the trademark (2633010) for 'Xydanra' till March 13, 2036.
Status: registered:
Registered/protected
Class: 5 [pharmaceutical drugs; pharmaceutical substances and preparations; pharmaceutical products and preparations; pharmaceutical preparations for human purposes; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the musculoskeletal system; pharmaceutical preparations for the treatment of various diseases; biochemical drug; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the treatment of bone diseases; pharmaceuticals for the treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations and substances for the treatment of cancer; pharmaceuticals for the prevention and treatment of cancer; pharmaceuticals for the treatment of cancer]
Type of Mark: Word
Date of Acceptance: March 27
Registration Advertised: Oct. 21
For further details contact Aborns Pharmaceuticals Pty. Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2633010.
Disclaimer: Curated by HT Syndication.